Goldman Sachs’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.6M | Buy |
3,523,917
+1,591,983
| +82% | +$14.3M | ﹤0.01% | 1444 |
|
|
2025
Q1 | $14.5M | Buy |
1,931,934
+640,704
| +50% | +$4.81M | ﹤0.01% | 1939 |
|
|
2024
Q4 | $9.71M | Sell |
1,291,230
-1,029,299
| -44% | -$7.74M | ﹤0.01% | 2364 |
|
|
2024
Q3 | $17.6M | Sell |
2,320,529
-209,730
| -8% | -$1.59M | ﹤0.01% | 1829 |
|
|
2024
Q2 | $15.6M | Buy |
2,530,259
+604,894
| +31% | +$3.74M | ﹤0.01% | 1753 |
|
|
2024
Q1 | $9.78M | Buy |
1,925,365
+150,611
| +8% | +$765K | ﹤0.01% | 2056 |
|
|
2023
Q4 | $10.6M | Buy |
1,774,754
+232,043
| +15% | +$1.39M | ﹤0.01% | 2035 |
|
|
2023
Q3 | $10.9M | Buy |
1,542,711
+63,922
| +4% | +$453K | ﹤0.01% | 1919 |
|
|
2023
Q2 | $10.4M | Buy |
1,478,789
+352,083
| +31% | +$2.48M | ﹤0.01% | 2006 |
|
|
2023
Q1 | $9.4M | Sell |
1,126,706
-4,988
| -0.4% | -$41.6K | ﹤0.01% | 2061 |
|
|
2022
Q4 | $13M | Sell |
1,131,694
-337,461
| -23% | -$3.87M | ﹤0.01% | 1930 |
|
|
2022
Q3 | $18.5M | Buy |
1,469,155
+92,443
| +7% | +$1.16M | ﹤0.01% | 1661 |
|
|
2022
Q2 | $14.6M | Buy |
1,376,712
+103,087
| +8% | +$1.09M | ﹤0.01% | 1839 |
|
|
2022
Q1 | $20.7M | Buy |
1,273,625
+459,965
| +57% | +$7.48M | ﹤0.01% | 1694 |
|
|
2021
Q4 | $11.3M | Buy |
813,660
+45,965
| +6% | +$637K | ﹤0.01% | 2179 |
|
|
2021
Q3 | $11M | Sell |
767,695
-42,467
| -5% | -$610K | ﹤0.01% | 2182 |
|
|
2021
Q2 | $12.8M | Sell |
810,162
-1,360,428
| -63% | -$21.5M | ﹤0.01% | 2070 |
|
|
2021
Q1 | $22.1M | Buy |
2,170,590
+1,866,955
| +615% | +$19M | 0.01% | 1611 |
|
|
2020
Q4 | $2.26M | Sell |
303,635
-1,166,305
| -79% | -$8.69M | ﹤0.01% | 2998 |
|
|
2020
Q3 | $5.05M | Sell |
1,469,940
-754,732
| -34% | -$2.59M | ﹤0.01% | 2379 |
|
|
2020
Q2 | $10.6M | Buy |
2,224,672
+760,132
| +52% | +$3.62M | ﹤0.01% | 1909 |
|
|
2020
Q1 | $2.93M | Buy |
1,464,540
+341,261
| +30% | +$683K | ﹤0.01% | 2550 |
|
|
2019
Q4 | $3.88M | Buy |
1,123,279
+80,648
| +8% | +$278K | ﹤0.01% | 2579 |
|
|
2019
Q3 | $2.99M | Buy |
1,042,631
+36,924
| +4% | +$106K | ﹤0.01% | 2614 |
|
|
2019
Q2 | $3.81M | Buy |
1,005,707
+622,093
| +162% | +$2.36M | ﹤0.01% | 2447 |
|
|
2019
Q1 | $3.12M | Buy |
383,614
+229,103
| +148% | +$1.86M | ﹤0.01% | 2698 |
|
|
2018
Q4 | $1.25M | Buy |
154,511
+10,043
| +7% | +$81K | ﹤0.01% | 3036 |
|
|
2018
Q3 | $1.1M | Buy |
144,468
+45,674
| +46% | +$348K | ﹤0.01% | 3150 |
|
|
2018
Q2 | $566K | Sell |
98,794
-1,615
| -2% | -$9.25K | ﹤0.01% | 3469 |
|
|
2018
Q1 | $479K | Sell |
100,409
-83,234
| -45% | -$397K | ﹤0.01% | 3517 |
|
|
2017
Q4 | $901K | Sell |
183,643
-177,294
| -49% | -$870K | ﹤0.01% | 3196 |
|
|
2017
Q3 | $1.89M | Sell |
360,937
-563,820
| -61% | -$2.95M | ﹤0.01% | 2917 |
|
|
2017
Q2 | $5.14M | Buy |
924,757
+137,068
| +17% | +$762K | ﹤0.01% | 2263 |
|
|
2017
Q1 | $6.62M | Buy |
787,689
+46,249
| +6% | +$388K | ﹤0.01% | 2048 |
|
|
2016
Q4 | $4.69M | Sell |
741,440
-155,302
| -17% | -$983K | ﹤0.01% | 2221 |
|
|
2016
Q3 | $3.96M | Sell |
896,742
-249,338
| -22% | -$1.1M | ﹤0.01% | 2372 |
|
|
2016
Q2 | $3.26M | Sell |
1,146,080
-91,338
| -7% | -$259K | ﹤0.01% | 2347 |
|
|
2016
Q1 | $3.5M | Buy |
1,237,418
+155,133
| +14% | +$439K | ﹤0.01% | 2245 |
|
|
2015
Q4 | $11.2M | Buy |
1,082,285
+52,515
| +5% | +$542K | ﹤0.01% | 1629 |
|
|
2015
Q3 | $11.7M | Sell |
1,029,770
-3,394
| -0.3% | -$38.7K | ﹤0.01% | 1558 |
|
|
2015
Q2 | $15.4M | Buy |
1,033,164
+596
| +0.1% | +$8.9K | ﹤0.01% | 1480 |
|
|
2015
Q1 | $9.33M | Buy |
1,032,568
+774,093
| +299% | +$6.99M | ﹤0.01% | 1698 |
|
|
2014
Q4 | $3.14M | Buy |
258,475
+223,158
| +632% | +$2.71M | ﹤0.01% | 2247 |
|
|
2014
Q3 | $345K | Buy |
35,317
+13,309
| +60% | +$130K | ﹤0.01% | 3559 |
|
|
2014
Q2 | $281K | Sell |
22,008
-4,333
| -16% | -$55.3K | ﹤0.01% | 3746 |
|
|
2014
Q1 | $279K | Sell |
26,341
-72,461
| -73% | -$767K | ﹤0.01% | 3725 |
|
|
2013
Q4 | $751K | Sell |
98,802
-86,139
| -47% | -$655K | ﹤0.01% | 3215 |
|
|
2013
Q3 | $1.35M | Sell |
184,941
-21,834
| -11% | -$159K | ﹤0.01% | 2757 |
|
|
2013
Q2 | $321K | Buy |
+206,775
| New | +$321K | ﹤0.01% | 3409 |
|